The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 21 November 2005. doi:10.1084/jem.20051194
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 10, 1327-1332
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1110K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, H.
Right arrow Articles by Dixit, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, H.
Right arrow Articles by Dixit, V. M.
Right arrowPubmed/NCBI databases
*Gene*Protein
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-{kappa}B activation

Honglin Zhou1, Denise M. Monack3, Nobuhiko Kayagaki1, Ingrid Wertz1, Jianpin Yin2, Beni Wolf1, and Vishva M. Dixit1

1 Molecular Oncology Department, Genentech, Inc., San Francisco, CA 94080
2 Protein Engineering Department, Genentech, Inc., San Francisco, CA 94080
3 Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305

CORRESPONDENCE Vishva Dixit: dixit{at}gene.com

The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor {kappa}B (NF-{kappa}B) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and I{kappa}B{alpha}. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-{kappa}B signaling by selectively removing K63-linked polyubiquitin chains that activate I{kappa}B kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of I{kappa}B{alpha}. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ.


I. Wertz's present address is Washington University School of Medicine, St. Louis, MO 63110.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

A plague of deubiquitination
Kendall Powell
J. Exp. Med. 2005 202: 1305. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS